Statistical and methodological concerns about the beneficial effect of neuraminidase inhibitors on mortality

Mark Jones^*, Chris Del Mar, Rokuro Hama

^*Corresponding author for this work

Research output: Contribution to journal › Letter › Research › peer-review

8 Citations (Scopus)

Original language	English
Pages (from-to)	9-10
Number of pages	2
Journal	The Lancet Respiratory Medicine
Volume	2
Issue number	7
DOIs	https://doi.org/10.1016/S2213-2600(14)70126-2
Publication status	Published - 2014

Access to Document

@article{f112e18a060f4e3a9c761bde2a394951,

title = "Statistical and methodological concerns about the beneficial effect of neuraminidase inhibitors on mortality",

author = "Mark Jones and {Del Mar}, Chris and Rokuro Hama",

year = "2014",

doi = "10.1016/S2213-2600(14)70126-2",

language = "English",

volume = "2",

pages = "9--10",

journal = "The Lancet Respiratory Medicine",

issn = "2213-2600",

publisher = "Elsevier",

number = "7",

}

TY - JOUR

T1 - Statistical and methodological concerns about the beneficial effect of neuraminidase inhibitors on mortality

AU - Jones, Mark

AU - Del Mar, Chris

AU - Hama, Rokuro

PY - 2014

Y1 - 2014

UR - http://www.scopus.com/inward/record.url?scp=84903943315&partnerID=8YFLogxK

U2 - 10.1016/S2213-2600(14)70126-2

DO - 10.1016/S2213-2600(14)70126-2

M3 - Letter

C2 - MEDLINE:24948431

AN - SCOPUS:84903943315

SN - 2213-2600

VL - 2

SP - 9

EP - 10

JO - The Lancet Respiratory Medicine

JF - The Lancet Respiratory Medicine

IS - 7

ER -